The use of the ex vivo Chandler Loop Apparatus to assess the biocompatibility of modified polymeric blood conduits.

The foreign body reaction occurs when a synthetic surface is introduced to the body. It is characterized by adsorption of blood proteins and the subsequent attachment and activation of platelets, monocyte/macrophage adhesion, and inflammatory cell signaling events, leading to post-procedural complications. The Chandler Loop Apparatus is an experimental system that allows researchers to study the molecular and cellular interactions that occur when large volumes of blood are perfused over polymeric conduits. To that end, this apparatus has been used as an ex vivo model allowing the assessment of the anti-inflammatory properties of various polymer surface modifications. Our laboratory has shown that blood conduits, covalently modified via photoactivation chemistry with recombinant CD47, can confer biocompatibility to polymeric surfaces. Appending CD47 to polymeric surfaces could be an effective means to promote the efficacy of polymeric blood conduits. Herein is the methodology detailing the photoactivation chemistry used to append recombinant CD47 to clinically relevant polymeric blood conduits and the use of the Chandler Loop as an ex vivo experimental model to examine blood interactions with the CD47 modified and control conduits.

[1]  M. Finley,et al.  Intracellular signaling mechanisms associated with CD47 modified surfaces. , 2013, Biomaterials.

[2]  M. Finley,et al.  Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces. , 2012, Biomaterials.

[3]  W. van Oeveren,et al.  Comparison of Modified Chandler, Roller Pump, and Ball Valve Circulation Models for In Vitro Testing in High Blood Flow Conditions: Application in Thrombogenicity Testing of Different Materials for Vascular Applications , 2012, International journal of biomaterials.

[4]  Dennis E Discher,et al.  The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation. , 2011, Biomaterials.

[5]  T. Berg,et al.  Innate immune ‘self’ recognition: a role for CD47–SIRPα interactions in hematopoietic stem cell transplantation , 2008 .

[6]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[7]  Dennis E. Discher,et al.  Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells , 2008, The Journal of cell biology.

[8]  R. Vasita,et al.  Improved biomaterials for tissue engineering applications: surface modification of polymers. , 2008, Current topics in medicinal chemistry.

[9]  Carsten Werner,et al.  In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces. , 2007, Biomaterials.

[10]  Shamik Sen,et al.  Species- and cell type-specific interactions between CD47 and human SIRPalpha. , 2006, Blood.

[11]  C. Werner,et al.  In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. , 2005, Biomaterials.

[12]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[13]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[14]  Reinhard Miller,et al.  Characterisation of the initial period of protein adsorption by dynamic surface tension measurements using different drop techniques , 1998 .

[15]  T. Thorsen,et al.  Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression. , 1993, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[16]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[17]  S. D. Bruck.  Medical applications of polymeric materials. , 1982, Medical progress through technology.